Trials / Completed
CompletedNCT06141577
A Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of UI059 and UIC202201 in Healthy Subjects
A Randomized, Open-label, Multiple-dose Crossover Phase 1 Clinical Trial to Compare and Evaluate the Safety, Pharmacokinetics and Pharmacodynamics Characteristics After Oral Administration of UI059 and UIC202201 in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Korea United Pharm. Inc. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
A randomized, open-label, multiple-dose crossover phase 1 clinical trial to compare and evaluate the safety, pharmacokinetics and pharmacodynamics characteristics after oral administration of UI059 and UIC202201 in healthy adult volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | UI059 | take UI059 1cap/day for 7 days |
| DRUG | UIC202201 | take UIC202201 1cap/day for 7 days |
Timeline
- Start date
- 2023-10-08
- Primary completion
- 2023-11-07
- Completion
- 2023-11-15
- First posted
- 2023-11-21
- Last updated
- 2023-11-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06141577. Inclusion in this directory is not an endorsement.